Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Discovery of factor XI
- Coagulation cascade
- A diagram of the human factor XI polypeptide
- Factor XI - gel filtration
- Intrinsic pathway protease deficiencies
- Tissue factor
- Plasma coagulation and coagulation factor
- Factor XI activation by thrombin on platelets
- Factor XI activation on the platelets surface
- Thrombin generation in platelet rich plasma
- Fibrin clot resistance to fibrinolysis - assay
- Fibrin clot resistance to fibrinolysis - results
- Thrombin activatable fibrinolysis inhibitor (TAFI)
- Summary: physiology of factor XI
- Bleeding in factor XI deficiency
- Mutations in factor XI
- Bleeding in factor XI deficiency: types II and III
- Factor XI deficiency - type II
- Factor XI A4 domain mutations
- Factor XI deficiency: types II and III
- Over 100 different mutations identified
- Factor XI deficiency
- Autosomal dominant factor XI deficiency?
- Factor XI deficiency: dominant mutations (1)
- Factor XI deficiency: kindred
- Factor XI deficiency: catalytic domain
- In vitro transfection system assay
- In vitro transfection system assay results
- Mutations effect on the secretion of wt factor XI
- Relative factor XI (%) in media and in lysates
- Factor XI deficiency - dominant mutations (2)
- Classification system for CRM factor XI deficiency
- Summary: factor XI deficiency
- Treatment: factor XI deficiency
- Inhibitors: factor XI deficiency
- Factor XI and thrombotic disease
- Factor IX and factor XI deficient mice
- Carotid artery occlusion: ferric chloride model
- Carotid artery injury model
- Factor XI deficient mice: ferric chloride model
- Factor XI deficient mice: effect of aspirin/heparin
- Summary: factor XI thrombotic disease
Topics Covered
- Discovery of coagulation factor XI
- Structure of factor XI
- Normal plasma coagulation
- Mechanisms for factor XI activation
- Inherited factor XI deficiency
- Factor XI in mouse thrombosis models
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Gailani, D. (2007, October 1). The physiology and pathology of coagulation factor XI [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/VKLQ1014.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. David Gailani has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.